2 CEs
Price
$39.99
See Provider Info

Add this webinar to your calendar:


Outlook

Google

Yahoo!

Webinar Description

 

Two Hour Online Webinar

Previously Recorded

 

 This 2 Hour Webinar includes a total of 2 CE Credits. The cost of the two hour webinar is $39.99.

To register for the webinar click "BUY IT NOW".

If you have any difficulty registering, please contact us here

 

 

 Vax Up or Mask Up! 

Understanding Covid 19 Vaccine Safety and Protective Efficacy

Originally Recorded on September 17, 2021

 

This new training meets the new DC Covid-19 training requirement.

Do you have questions about the Covid-19 vaccine? Are you unsure of the benefits of the vaccines? Concerned about it's safety? Are you struggling with helping your clients or patients understand the benefits of the vaccines? This new training with vaccine development specialist Dr. Robert Edelman, MD, will answer many of the questions that people have regarding the Covid-19 vaccines.  

Among the topics addressed will be why some people get sicker from Covid than others, and what we know about how long the vaccine lasts. We will also discuss the Delta variant and why it changed our lives suddenly after dealing 17 months with the earlier covid strains. 

What is mRNA and does it affect my DNA? If I already had Covid should I get vaccinated? Do I still need two doses, or maybe just one? This brand new training meets the new DC Covid-19 training requirement. Earn 2 CE credits. 

 

(Trainer, Dr. Robert Edelman, MD is currently a Professor Emeritus of Medicine on vaccine development at the University of Maryland (UM) Center for Vaccine Development and Global Health (CVD). His projects include the biotechnology industry, major pharmaceutical houses, the World Health Organization (WHO), the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID), the Department of Defense, the U.S. Agency for International Development, and the Gates Foundation's Malaria Vaccine Initiative and Pediatric Dengue Vaccine Initiative.

Dr. Edelman served as the Associate Director for Clinical Research at the CVD from 1988 until 2011 when he became the Associate Director for Regulatory Affairs and Bioethics. Dr. Edelman’s experience includes leading clinical trials for experimental vaccines, licensed vaccines, and biologicals against a variety of infectious diseases for adult and pediatric volunteers. He was the principal investigator for the University of Maryland Immunosenescence/Immunosupression Research Group.

Dr. Edelman is a recognized expert in clinical trials of vaccine adjuvants. He is interviewed and quoted widely on vaccines against bioterror agents, influenza, dengue, and other emerging infections. He was a member of the WHO Advisory Committee on Dengue and other Flavivirus vaccines for five years and directed the Travelers’ Health Clinic at the UM Medical Center for 20 years. Dr. Edelman served as Chairman of the UM Institutional Review Board (IRB) for nine years and ran a mentoring program for the entire faculty of University of Maryland School of Medicine on conducting clinical research. Dr. Edelman has co-edited a book, authored 187 peer-reviewed papers, 29 book chapters, 80 abstracts, and has 13 invited editorials and book reviews.

Dr. Edelman served in both the United States (US) Army and the US Public Health Service (USPHS) prior to joining the faculty at UM. His experiences include investigating the pathogenesis and epidemiology of arbovirus infections, the relationship between malnutrition and immunity, and performing Phase 1 clinical trials for several viral vaccines, including vaccines against the bioterror agents, tularemia and Venezuelan equine encephalomyelitis virus. Dr. Edelman served as Deputy Director of the Microbiology and Infectious Disease Program at NIAID and as Chief of the Clinical and Epidemiological Studies Branch. During this time, his clinical research included Lyme disease, maternal vaginal infections as a cause of low infant birth weight, epidemiology of AIDS, and clinical trials of new antifungal drugs.)

This 120 minute webinar includes a total of 2 CE Credits. The cost of the two hour webinar is $39.99.

Date of CE Release: September 10, 2021
Date of CE Expiration:
September 10, 2022

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and CE You!  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)
Amedco LLC designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. 

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

First Name

Last Name

Commercial Interest : Relationship

Jeffrey

Davidson

NA

Robert

Edelman

NA

Scott

McGee-Plys

NA 


Learning Objectives:

  • Participants will be able to explain basic vaccine safety and protective efficacy to their clients.
  • Participants will understand how the the covid 19 vaccines contribute to curtailing the covid 19 pandemic.
This presentation is open to:
  • Social Workers
  • Professional Counselors
  • Therapists
  • Psychologists
  • Licensed Mental Health Practitioners
  • Other professionals interacting with populations engaged in mental health based services
This online class is offered at an introductory level ,and is beneficial for a beginner level clinician:
  • New practitioners who wish to gain enhanced insight surrounding the topic
  • Experienced practitioners who seek to increase and expand fundamental knowledge surrounding the subject matter
  • Advanced practitioners seeking to review concepts and reinforce practice skills and/or access additional consultation
  • Managers seeking to broaden micro and/or macro perspectives


    • CE You LLC #1573 is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CE You LLC maintains responsibility for this course. ACE provider approval period {valid_date}. Social workers completing this course receive {num_ceu} continuing education credits.
    • CE You! is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland. CE You! maintains responsibility for this program..
    • CE You LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0437
    • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and CE You! Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Successful completion of this program qualifies for up to 2.00 AMA PRA Category Credit(s) TM.

Official information:

Refund Policy: Full Refund until 48 hours before scheduled date. 48 hours before: full refund less $5.00 processing fee. After event no refund will be given.

*exclusions apply for reasonable need and cause.

Disability Access: If you require ADA accommodations, please contact our office 30 days or more before the event. We cannot ensure accommodations without adequate prior notification.
Please Note: Licensing Boards change regulations often, and while we attempt to stay abreast of their most recent changes, if you have questions or concerns about this course meeting your specific board’s approval, we recommend you contact your board directly to obtain a ruling.
The grievance policy for trainings provided by the NEFESH INTERNATIONAL is available here
Satisfactory Completion: Participants must have paid the tuition fee, logged in and out each day, attended the entire webinar, and completed an evaluation to receive a certificate (If this is a pre-recorded program, a post-test with a passing grade of 80% to receive a certificate.) Failure to log in or out will result in forfeiture of credit for the entire course. No exceptions will be made. Partial credit is not available. Certificates are available after satisfactory course completion by clicking here
Participants will receive their certificate electronically upon completion of the webinar and course evaluation form.
Browse Other Webinars Go to Buy Now